Scientific Advisory Board

Destiny Pharma has a Scientific Advisory Board (SAB) of key opinion leaders in relevant fields to help guide and inform the future clinical development of the XF platform.  Our SAB includes the following members: David Roblin MD FRCP FFPM FMedSci (SAB Chairman) Professor David Roblin is President of Research and Development at Summit Therapeutics. David […]

AmpliPhi Biosciences to Present at 5th World Congress on Targeting Infectious Diseases: Targeting Phage & Antibiotic Resistance 2018

riday, May 18, 2018 6:50 am EDT SAN DIEGO PUBLIC COMPANY INFORMATION: “We are delighted to participate in TID 2018 and to share our product development experience and clinical perspective on the promise of phage therapeutics as a potential treatment for combatting increasing, and potentially life-threatening, antibiotic resistance” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: […]

Adherium’s Technology Used for Large Scale Electronic Data Capture in Landmark Mild-Asthma Trials

18 May 2018 San Mateo, CA – May 18, 2018: Adherium (ASX: ADR), a digital health company that improves medication adherence and patient outcomes, announced the extensive use of it’s Hailie™(previously known as Smartinhaler™) technology in two landmark clinical trials investigating the treatment of mild asthma, which have just been published in the New England Journal […]

Adherium Launches the Hailie™ Global Brand to Connect People with Asthma and COPD to Better Care

17 May 2018 San Mateo, CA – May 16th, 2018: Adherium (ASX: ADR), an award-winning digital health company that improves medication adherence, patient outcomes and engagement, today announced the launch of the Hailie™ global brand to connect people with asthma and COPD to better care. The launch is a rebrand of the existing Smartinhaler™ brand, and […]

New medical device platform takes flight: Global Health Sciences Fund invests in Canary Medical’s proprietary, “smart” implant technology designed to improve outcomes in post-surgical patients

The Canary Health Implantable Reporting Processor (CHIRP) uses innovative sensor and novel communication technology in medical devices to enable remote patient monitoring. “Smart” medical devices will self-report on everything from patient activity to recovery and even treatment failure, without the need for physician intervention or a dependence upon patient compliance. May 17, 2018 13:06 ET […]

AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights

Announced positive topline results for the initial seven patients treated with AB-SA01 or AB-PA01 under ongoing expanded access program and presented detailed results for the first patient at a medical conference  Signed collaborative agreements with the U.S. Department of Veterans Affairs and the Westmead Hospital in Sydney  Completed two financings for combined gross proceeds of […]

Adherium to Present at the Chardan Digital Health Conference

15 May 2018 San Mateo, CA – May 1, 2018: Adherium, an award-winning digital health company that improves medication adherence and patient outcomes, today announced the Company will be participating in the upcoming Chardan Digital Health Conference in San Francisco, CA on Tuesday, May 22, 2018. Arik Anderson, CEO, is scheduled to provide a business overview […]

Live Better With: World No Tobacco Day 2018

When is World No Tobacco Day? World No Tobacco Day takes place annually on May 31. What is the reason for World No Tobacco Day? World No Tobacco Day is an annual awareness day sponsored the World Health Organization (WHO) since 1987 to highlight the health risks associated with tobacco use and encourage governments to […]

Introducing Evaux – the skincare range made for cancer patients

We’re always on the lookout for new, innovative, and most importantly helpful products to add to our growing catalogue. The newest addition to our site is the Evaux skincare range – developed especially for cancer patients. During chemo or radiotherapy, you may find that your usual skincare and beauty products do more harm than good. It may be time […]

AmpliPhi Biosciences Will Utilize NIAID Preclinical Services to Advance Development of Its Targeted Therapeutic Candidate for the Treatment of Resistant Staphylococcus Aureus

PUBLIC COMPANY INFORMATION: NYSEAM: APHB “We are pleased and encouraged the support from the NIAID and its commitment to studying the role of bacteriophage in combating infectious diseases” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it will […]